We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Speaker: Prof. Alejandro Lucía Mulas, member of the Department of Sports Science. Faculty of Medicine, Health and Sports. European University of Madrid.
Abstract: A growing body of epidemiological, clinical and experimental evidence indicates that regular physical activity reduces cancer risk, improves survival, and may decrease the likelihood of tumour recurrence. Beyond its well-established effects on metabolic and cardiovascular health, exercise is increasingly recognized as a potent modulator of immune function.
Both acute exercise bouts and long-term exercise training induce dynamic changes in immune cell mobilization, trafficking and function. These adaptations may enhance cancer immunosurveillance through multiple mechanisms, including the redistribution of cytotoxic lymphocytes, improved immune cell infiltration into tumours, modulation of inflammatory pathways, and favourable changes in the tumour microenvironment. Emerging evidence from animal models suggests that exercise can delay tumour growth, even in aggressive malignancies, whereas early human studies are beginning to uncover exercise-induced immune signatures associated with improved clinical outcomes.
This lecture will provide an overview of the current evidence linking exercise and anticancer immunity, spanning findings from basic science to clinical oncology. Particular emphasis will be placed on the role of natural killer cells, T lymphocytes, myeloid populations, and exercise-induced systemic factors as potential mediators of tumour control. The translational implications of this field will also be discussed, including the integration of exercise into cancer care and the potential of exercise-enhanced immune approaches as novel therapeutic strategies.
Host: Dr. Tomàs Pinós, senior researcher Neuromuscular and Mitochondrial Pathology (VHIR)
Online assistance: https://gencat.zoom.us/j/81888808680
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.